Elanco Receives USDA License for Canine Virus Treatment
May 02 2023 - 9:21AM
Dow Jones News
By Rob Curran
Elanco Animal Health received a conditional U.S. Department of
Agriculture license for the treatment of a common canine virus.
The veterinary-medicine maker said its Canine Parvovirus
Monoclonal Antibody targets a highly contagious virus that has a
mortality rate of 91% in dogs, if untreated.
Elanco, which was spun off from Eli Lilly & Co. in 2019,
said it expects to begin shipping the product in the coming weeks,
pending state approvals.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
May 02, 2023 09:06 ET (13:06 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Elanco Animal Health (NYSE:ELAN)
Historical Stock Chart
From Feb 2025 to Mar 2025
Elanco Animal Health (NYSE:ELAN)
Historical Stock Chart
From Mar 2024 to Mar 2025
